DP Clinical combines a strong neurology/CNS research heritage with over 25 years of experience in conducting acute and chronic spinal cord injury (SCI) clinical trials. Since 1994, DP Clinical has worked on almost all of the major acute and chronic SCI studies conducted, starting with the benchmark study of Sygen® (GM1)– considered the gold standard in SCI treatment – as well as studies using autologous macrophages, stem cells, and devices. Our relationships with SCI industry leaders and key professionals, including Neurosurgeons and Physical Medicine and Rehabilitation (PM&R) physicians, allow us to provide deeper insights and strategic guidance, leading to better patient experiences, improved clinical outcomes, and consistent efficacy assessments.

DP Clinical is at the forefront in shaping clinical research in the SCI space and supports the following organizations:

  • American Spinal Cord Injury Association (ASIA)
    • Chair of ASIA’s International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) Training Committee
    • Membership Committee
    • Autonomic Function Committee
    • Co-moderating the Round Room discussion during ASIA’s annual meeting Topic: Helping People with SCI Navigate Clinical Trials: From Acute Care to Living in the Community
  • Spinal Cord Outcomes Partnership Endeavor (SCOPE)
    • ASIA Clinical Trials 360 Presentation Subcommittee
  • Unite 2 Fight Paralysis
    • Serve on Board of Directors
  • International Neurotrauma Society
  • The North American Spinal Cord Injury Consortium (NASCIC)
  • National Institute of Neurological Disorders and Stroke (NINDS) Spinal Cord Injury Common Data Elements Oversight Committee for the Spinal Cord Injury CDE project

DP Clinical’s neurology/CNS trial experience includes the following indications:

  • Acute Spinal Cord Injury
  • Alzheimer’s Disease
  • Attention Deficit Hyperactivity Disorder (ADHD)
  • Autologous Macrophages for Spinal Cord Injury
  • Chronic Spinal Cord Injury
  • Head Injury
  • Ischemic Stroke
  • Multiple Sclerosis
  • Muscle relaxant, Anti-inflammatory
  • Neuropathic Pain
  • Parkinson’s Disease
  • Schizophrenia
  • Stem Cells for Spinal Cord Injury
  • Tourette Syndrome